The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PTC Therapeutics Inc shares valued at $63,370 were sold by Jacobson Allan Steven on Mar 04 ’25. At $51.52 per share, Jacobson Allan Steven sold 1,230 shares. The insider’s holdings dropped to 19,118 shares worth approximately $1.01 million following the completion of this transaction.
Also, Jacobson Allan Steven purchased 1,230 shares, netting a total of over 63,365 in proceeds.
Before that, Utter Christine Marie had sold 879 shares from its account. In a trade valued at $44,034, the SVP, CHIEF ACCOUNTING OFFICER traded PTC Therapeutics Inc shares for $50.10 each. Upon closing the transaction, the insider’s holdings decreased to 879 shares, worth approximately $3.35 million.
As published in a research note from Morgan Stanley on December 13, 2024, PTC Therapeutics Inc [PTCT] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $67 from $45. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in early December. Earlier on September 04, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PTCT stock.
Analyzing PTCT Stock Performance
During the last five days, there has been a surge of approximately 4.41%. Over the course of the year, PTC Therapeutics Inc shares have jumped approximately 16.97%. Shares of the company reached a 52-week high of $55.60 on 03/03/25 and a 52-week low of $41.67 on 01/14/25. A 50-day SMA is recorded $47.65, while a 200-day SMA reached $39.99.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 51.12, which, if violated, would cause prices to drop to 49.43. In the upper region, resistance lies at 53.66. The next price resistance is at 54.51. RSI (Relative Strength Index) is 59.75 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.80, which suggests the price will decrease in the coming days. Percent R is at 24.80%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
